Background: In the recent days there has been an increase in diseases known as "angiogenic diseases" characterized by pathologic vascularisation. In the rat, the development of embryonic vessel starts to occur at 9.5 days of gestation. In mammals, the vascular system starts developing in a very early embryonic stage. The majority of rat embryo circulation system gets complete approximately at 11 -12 days. Therefore the in vitro study of 9.5 -11.5-day old embryo culture could be a suitable model to study the effects of angiogenic and antiangiogenic substances on yolk sac vascularisation. In the present study, the effects of Interleukin-12 (IL-12) on the yolk sac vascularisation are investigated during the in vitro embryo culture, where the latter angiogenic factor was added to serum. Methods: After 48-hour culture period, effects of different doses of IL-12 (50 ng/ml, 100 ng/ml, and 200 ng/ml) were estimated morphologically. Results: According to morphologic scoring system, the total morphologic score, yolk sac diameter, crown rump length, and somite number were retarded in all experimental groups when compared to control. These developmental retardations were statically signifi cant. There was also a poor development in the yolk sac vascularisation and the heart. Conclusion: As a result, the IL-12 could cause developmental retardation of embryos owing to its antiangiogenic effect (Tab. 3, Fig. 2, Ref. 39). Text in PDF www.elis.sk.
The cardiovascular system is the earliest system to begin its development in order to take over the functional role in providing the metabolic requirements for a rapidly growing embryo (1) . In rats, the primordia of blood vessels appear around the day 9.5 of gestation, i.e. when the mesodermal germ layer is formed. Blood islands develop in the wall of the yolk sac as somites begin to form but there is no vascular connection with the vessels developing in situ in the body of the embryo. After blood islands are formed, they fuse and give rise to a primary vascular plexus (2, 3) . Then by day 11-12 of gestation, the circulatory system is established. At this time the nutritional and informational molecules are transported via the vessels from the yolk sac to the embryo (4) .
The formation of new blood vessel is a complex and controlled process in normal embryonic development, female reproductive cycle and wound healing (2) .
Vasculogenesis and angiogenesis are the major forms of blood vessel formation. Vasculogenesis is the formation of blood vessels in situ from angioblast whereas angiogenesis is the process where new vessels grow from pre-existing blood vessels (5) .
Angiogenesis depends on the balance between angiogenic and antiangiogenic factors. Previous studies reported that Interleukin-12 (IL-12) has an antiangiogenic effect on vessel development (6) (7) (8) .
IL-12 is a glycoprotein heterodimer of 75 kD and a strong pro-infl ammatory cytokine (9) . IL-12 is composed of α-chain (p35 subunit) and a β-chain (p40 subunit) linked by disulphide bridge to form the biologically active 74 kDa heterodimer. It is produced by phagocytic cells, B cells and dendritic cells (10) . IL-12 is recognized as a master regulator of adaptive type 1, cell-mediated immunity, the critical pathway involved in protection against neoplasia and many viruses. This is supported by the analysis of numerous animal (11, 12) and human clinical studies that can be attributed to improved clinical outcome (13) and mechanisms of IL-12-based therapy (14) to strong type 1 responses in situ. Since the initial preclinical and clinical studies of IL-12, done over a decade ago, the basic and translational science studies have contributed to the greater understanding of IL-12 immunobiology. In addition to its noted effects in the priming of T helper 1 (TH1) cell responses and interferon-gamma (IFN-γ) production by T and natural killer (NK) cells, more recent studies support its critical role as a third signal for CD8+ T cell differentiation (15, 16) , and its ability to serve as an important factor in the reactivation and survival of memory CD4+ T cells (17) . This is particularly relevant in the repolarisation of CD4+ T cells from dysfunctional antitumour T helper 2 (TH2) into TH1 cells in the cancer setting (18) .
The in vitro culture of post-implantation rat embryos from 9.5 to 11.5 days is possible in homologous serum using the method described by New (19) , such that the development of embryos in vitro is comparable to that in vivo (20). Brunda et al (6) , as well as Tahara et al (21) and Nastala et al (22) showed that IL-12 has a potent in vivo antitumor and antimetastatic activity against murine tumors. In addition, an important pro-infl ammatory cytokine, IL-12 has been shown to have a potent immunomodulatory, antitumour, and anti-infection activity in vitro and in vivo (23) . Several studies (1, (24) (25) (26) have been carried out to explain the effects of vascular endothelial growth factor (VEGF), anti-fi broblast growth factor-2 (anti-FGF-2 or anti-bFGF), fi broblast growth factor-9 (FGF-9) and angiostatin (K1-3) by using embryo culture technique in rats. But there are no data about IL-12´s embryotoxicity or teratogenicity. The aim of the present study was to investigate the in vitro effects of interleukin-12 on embryonic development during the period of organogenesis in the rat.
Methods

Timing of mating and pregnancy
All protocols were approved by the Animal Care and Use Committee (Ethics Committee) of Erciyes University. Wistar rats were obtained from the Clinical and Experimental Research Centre, Medical Faculty of Erciyes University. The female rats (approximately at 8 weeks of age and weighing (175-200 g) were paired with their male partners in cages at about 5:00 pm and left overnight. The females were checked for the presence of vaginal plugs as an indication of mating and hence fertilisation. On the assumption that mating occurred around midnight, the female was considered to be 0.5-day pregnant at noon the following day.
Culture of the whole embryo
At 9.5 days of gestation, the embryos (approximately 10 embryos from each pregnant rat) were removed from the mother by explantation procedure described by New (19) . The pregnant rat was anaesthetised with diethyl ether. When complete anaesthesia was achieved, as assessed by the lack of blink refl ex, the animals were placed in a supine position with a nose cone containing ether-soaked pads placed over the nose to ensure continual anaesthesia. The abdomen was cleaned with 70 % ethanol and opened by midline incision in the anterior wall, and the viscera with their mesenteries were cleared to expose the bifurcation of the abdominal aorta into the common iliac arteries. A volume of 8-10 ml of blood was withdrawn from the aorta with a 10-ml syringe and immediately centrifuged at 3,000 revolutions per minute for fi ve minutes to obtain serum which was used as culture medium. The uterine horns containing the conceptuses were excised and placed in Hank's balanced salt solution (HBSS) (Sigma) at 37 °C.
After this stage, the procedure was carried out in a laminar fl ow cabinet. The uterus was cut into individual conceptuses, and by using jeweller's forceps, the uterine tissue was separated from the roundish decidua by making an incision along its superior border. Through the incision, the decidua were gently removed and placed into fresh HBSS at 37 °C. Under a dissecting microscope, the decidual tissue around the conceptus was dissected and one half removed so that the conceptus was left in the other half. The conceptus was gently and carefully dislodged into HBSS. While taking care not to damage the closely apposed visceral yolk sac, the parietal yolk sac and Reichert's membrane were removed by grasping them with two pairs of forceps at the embryonic pole of the egg cylinder and ripping the membrane along its length, finally removing it completely at the base of the ectoplacental cone.
Occurring the experimental groups
In order to assess the effect of IL-12 (Sigma-Aldrich, USA) on total embryonic growth, embryos were divided into a total of four groups (10 embryos per one group) of which one was a control and three were experimental. The control group of embryos was cultured in whole rat serum (WRS). The administration dosages of IL-12 were determined according to the data gained from previous studies (10, 27) . Experimental groups were cultured 50, 100 and 200 ng/ml IL-12 per embryo. The embryos were cultured according to the method described by New (19) . After 48-hour culture, the embryos from each group were examined under a dissecting microscope and assessed according to the morphological scoring system which takes account of the growth and differentiation of different embryological features, including the appearance of yolk sac circulation, allantois, body fl exion, heart, caudal neural tube, hindbrain, midbrain, forebrain, otic system, optic system, olfactory system, branchial arches (bars), maxillary processes, mandibular processes, forelimbs, hindlimbs and somite number (28) .
The data of morphological score and somite number, yolk sac diameter and crown-rump length were statistically analysed. All datasets were subjected to normality test using the KolmogorovSmirnov method and the data were reported as either mean ± standard deviation (x ± SD) (for normally distributed data) or as median with 25-75 % percentile (for skewed data). Comparison between the groups was made using the One Way Analysis of Variance (ANOVA; multiple comparisons were carried out with Tukey Test) or the Kruskal-Wallis Test (KW; Post-Hoc comparisons were carried out with Tukey Test). Statistical signifi cance was set at P<0.001. All analyses were performed with the statistical package for scientist (SIGMASTAT) Windows version 3.10.
Results
The embryos cultured in IL-12 showed severe growth retardation in all embryonic primordia when compared to embryos grown only in WRS (Figs 1 and 2 ). IL-12 affected the embryos in a dose-dependent manner and higher doses of IL-12 increased the retardations of embryonic growth and development according to morphological scoring system (Tabs 1 and 2) . The lower morphological scores were accompanied by poor yolk sac vessel development according to the scoring system, some failure of fusion of the neural folds, incomplete embryonic fl exion, and retarded development of otic, optic and olfactory systems, branchial bars, maxillary and mandibular processes and limbs. In addition to total morphological scores, the yolk sac diameter, somite numbers and the crown-rump length of 11.5-day embryos grown in IL-12 was signifi cantly decreased compared to normal embryonic development on day 11.5 in WRS. Statistical studies showed that there was a signifi cant decrease (p < 0.001) in total morphological score, yolk sac diameter, crown-rump length, and somite number. Mean morphological scores for the embryos grown in WRS in the presence of 50, 100 and 200 ng/ml IL-12 were 58.45 ± 0.47, 53.20 ± 1.23, 50.90 ± 1.53 and 41.30 ± 2.93, respectively. Yolk sac diameter was 3.17 ± 0.14 mm in control group and 2.86 ± 0.14, 2.60 ± 0.12 and 2.31 ± 0.13 mm in experimental groups, respectively.
While in the control group, the mean crown-rump length was 3.17 ± 0.14 mm, in experimental groups it diminished gradually due to the dose of IL-12 (2.86 ± 0.14, 2.60 ± 0.12 and 2.31 ± 0.13 mm). Median value of the somite numbers was 24 (24-25) in control group and it was diminished to 23 (21-23), 21 (20-21) and 17 (16) (17) , respectively in experimental groups. While the yolk sac of embryos grown in WRS had a fully developed yolk sac plexus of vessels, the yolk sac of embryos grown in WRS + 100 ng/ml IL-12 was just establishing the vitelline circulation and had few yolk sac vessels, and the WRS + 200 ng/ml IL-12 groups had no vessels and still had only blood islands ( Figs 1A and B) . Developmental retardations in the neural tube formation were also found in all experimental groups when compared to control group. There was an open neural tube in both cranial and caudal regions in the embryos that had been grown in the presence of IL-12 (Figs 2A and B) . While the three-chambered heart of embryos grown in rat serum was normal (2 atrial, 1 ventricular), the heart development in embryos grown in the presence of IL-12 had not reached this level (Tab. 3) .
The morphological analysis showed that all embryos grown in WRS+IL-12 had open caudal neural tubes and less of neural system developed. In conclusion, IL-12 caused growth retardation in all experimental groups.
Discussion
Since the longevity of people suffering from cancer is increasing a lot of studies are striving to improve their quality of life. Early detection of cancer as a result of fi nding better methods of assessment is in progress. On the other hand, methods used for cancer treatment (such as chemotherapy, radioterapy) have many side effects. Recently some studies emerged focused to reduce these side effects. The purpose of this research is to eliminate only cancer cells without harming the normal cells. In recent years, similar studies have been widely acknowledged. Recent studies have shown that some experimental antiangiogenic drugs are reliable in cancer treatment. In addition, the drugs used in these studies show that they prevent vascularisation and then eliminate the cancer cells. However, today the commonly used treatments have fewer side effects (29) (30) .
There are many antiangiogenic drugs preventing the fi rst new blood vessel formation. Endothelial cells grow in the inner layer of blood vessels. These new blood vessels cannot occur without endothelial cells. Some antiangiogenic drugs made in laboratory are proteins in structure and are the same proteins as those in the organism. These proteins reduce the growth of endothelial cells. They include e.g. Endostatin (31), Angiostatin (32) and Thrombospondin 1 (33) ve IL-12 (10)'dir.
Embryonic and adult growth processes are a pre-requisite for the formation of a functional vascular system, which is essential for proper development of vertebrate embryos, as well as for growth, regeneration and survival of adults (26) . The formation 
Tab. 1. Statistical analyses of in vitro embryonic development in whole rat serum (WRS), and interleukin-12 (IL-12).
of vascular system is one of the earliest and most important events during organogenesis in the developing embryo because the growing organism needs a transportation system to supply oxygen and nutrients and to remove waste products. Two distinct processes termed vasculogenesis and angiogenesis lead to the development of a complex vasculature covering the entire body (34) . Angiogenesis refers to the process of new blood vessel formation from a pre-existing vasculature which occurs either under physiological or pathological conditions (35) . Vasculogenesis is a de novo process by which the progenitor stem cells differentiate and give rise to a replacement vascular network (36).
Brunda et al (6) , as well as Tahara et al (21) and Nastala et al (22) showed that IL-12 has a potent in vivo antitumour and antimetastatic activity against murine tumours. Interestingly, the effi cacy of IL-12 in immune-incompetent mice was greatly reduced, but not abolished. By building on these observations, in 1995, Folkman and colleagues discovered the potent antiangiogenic properties of IL-12. They found that IL-12 treatment inhibited basic fi broblast growth factor-induced corneal neovascularization in both immunocompetent and immunodefi cient mice. Suppression of angiogenesis by IL-12 was dependent on its ability to induce IFN-γ expression. Accordingly, administration of IFN-γ reproduced the antiangiogenic effects promoted by IL-12 (37) . IL-12 treatment was shown to almost completely inhibit corneal neo-vascularisation in mice (10) . This potent suppression of angiogenesis was prevented by the administration of IFN-γ neutralizing antibodies, suggesting that the suppression was mediated through IFN-γ. In addition, the administration of IFN-γ reproduced the anti-angiogenic effects observed during treatment with IL-12 (37) . Thus, IL-12 strongly inhibits neo-vascularization and this effect is not mediated by a specifi c cell type of the immune system. Instead, IL-12 induces IFN-γ that appears to play a critical role as a mediator of the anti-angiogenic effects of IL-12 (38) .
In a different experimental model, researchers showed that the systemic administration of IL-12 and intermittent doses of IL-2 induced a complete regression of metastatic murine renal carcinoma, preceded by recruitment of CD8+ T cells, vascular injury, disrupted tumour neo-vascularisation, and apoptosis of Indeed, some recent studies have shown that IL-12 may mediate anti-tumour and anti-angiogenic effects dependent on induction of IFN-γ and CXCR3 ligands but requiring neither NK nor T cells. IL-12 was demonstrated to be able to induce an anti-angiogenesis effect of IL-12 on human as well as on murine tumours in NKdepleted SCID mice using fi broblasts genetically engineered to secrete this cytokine. The neo-vascularisation surrounding the tumour was remarkably inhibited in the area in which the IL-12-secreting fi broblasts were implanted, resulting in the suppression of tumour growth. Lectin staining in tumour sample sections also showed a signifi cant reduction in the number of vessels. The RNA expression of IFN-γ and IP-10 was stimulated in endothelial cells cultured with IL-12. It was also found that IL-12 downregulated the expression of the endothelial cell mitogens vascular endothelial growth factor and basic fi broblast growth factor (27) .
The effect of IL-12 was investigated in vitro on embryonic yolk sac vascularisation. In this research, depending on the dose, it was found to inhibit the development of yolk sac and heart vascularisation. In addition, the total development of embryos grown in the culture media with IL-12 declined greatly.
In the present study, in vitro effects of IL-12 were tested on embryo culture. The results showed that total embryonic growth was normal in WRS as opposed to the experimental groups in which IL-12 was added to WRS and decreased depending on the dose of IL-12. Embryonic retardations were seen in total embryonic growth especially yolk sac diameter and vascularisation, crown-rump length, somite number, body fl exion and neural tube development. When post-implantation embryos were cultured in the presence of certain antiangiogenic molecules, similar regression was seen in embryonic growth, e.g with anti-bFGF (24) and angiostatin (26) . Our results indicated that the addition of higher concentrations of IL-12 resulted in growth retardation and some malformations. Those fi ndings may be caused by the reduction in yolk sac functions, because the yolk sac decreased in size and vascularisation in the presence of these higher concentrations. It is well known that the yolk sac is an especially important placental organ in rodents at this time of embryonic development. It has been shown to be the primary source of exchange between the embryo and mother during early embryogenesis before the chorioallantoic placenta becomes functional (19) . Together with a wide range of other in vitro studies dealing with the teratogenicity of several different molecules, the present fi ndings suggest that the rat postimplantation embryo culture system is a very useful method for teratological studies and also particularly suitable for the assessment of specifi c effects on morphogenetic events occurring during early organogenesis in mammalian embryos.
